Isola J - Search Results

1

Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy.

Kuukasjärvi T, Kononen J, Helin H, Holli K, Isola J. Kuukasjärvi T, et al. Among authors: isola j. J Clin Oncol. 1996 Sep;14(9):2584-9. doi: 10.1200/JCO.1996.14.9.2584. J Clin Oncol. 1996. PMID: 8823339

2

Association of c-erbB-2 protein over-expression with high rate of cell proliferation, increased risk of visceral metastasis and poor long-term survival in breast cancer.

Kallioniemi OP, Holli K, Visakorpi T, Koivula T, Helin HH, Isola JJ. Kallioniemi OP, et al. Among authors: isola jj. Int J Cancer. 1991 Nov 11;49(5):650-5. doi: 10.1002/ijc.2910490504. Int J Cancer. 1991. PMID: 1682277

3

Immunocytochemical detection of estrogen and progesterone receptors in 124 human breast cancers.

Helin HJ, Helle MJ, Helin ML, Isola JJ. Helin HJ, et al. Among authors: isola jj. Am J Clin Pathol. 1988 Aug;90(2):137-42. doi: 10.1093/ajcp/90.2.137. Am J Clin Pathol. 1988. PMID: 2456008

4

Influence of endocrine status on biochemical and immunocytochemical estrogen and progesterone receptor assays in breast cancer patients.

Helin HJ, Isola JJ, Helle MJ, Adlercreutz H. Helin HJ, et al. Among authors: isola jj. Breast Cancer Res Treat. 1988 Sep;12(1):67-73. doi: 10.1007/BF01805742. Breast Cancer Res Treat. 1988. PMID: 3196886

5

Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer.

Siitonen SM, Kononen JT, Helin HJ, Rantala IS, Holli KA, Isola JJ. Siitonen SM, et al. Among authors: isola jj. Am J Clin Pathol. 1996 Apr;105(4):394-402. doi: 10.1093/ajcp/105.4.394. Am J Clin Pathol. 1996. PMID: 8604681

6

Predictive value of topoisomerase IIalpha and other prognostic factors for epirubicin chemotherapy in advanced breast cancer.

Järvinen TA, Holli K, Kuukasjärvi T, Isola JJ. Järvinen TA, et al. Among authors: isola jj. Br J Cancer. 1998 Jun;77(12):2267-73. doi: 10.1038/bjc.1998.377. Br J Cancer. 1998. PMID: 9649144 Free PMC article.

7

Immunocytochemical detection of progesterone receptor in breast carcinoma. Comparison of two monoclonal antibodies.

Isola JJ, Helle MJ, Helin HJ. Isola JJ, et al. Am J Clin Pathol. 1990 Mar;93(3):378-82. doi: 10.1093/ajcp/93.3.378. Am J Clin Pathol. 1990. PMID: 1689943

8

Immunohistochemical versus biochemical estrogen-receptor and progesterone-receptor analysis: correlation with histological parameters.

Helle M, Helin M, Isola J, Helin H. Helle M, et al. Among authors: isola j. J Cancer Res Clin Oncol. 1989;115(4):361-5. doi: 10.1007/BF00400963. J Cancer Res Clin Oncol. 1989. PMID: 2760100

9

Cathepsin D expression detected by immunohistochemistry has independent prognostic value in axillary node-negative breast cancer.

Isola J, Weitz S, Visakorpi T, Holli K, Shea R, Khabbaz N, Kallioniemi OP. Isola J, et al. J Clin Oncol. 1993 Jan;11(1):36-43. doi: 10.1200/JCO.1993.11.1.36. J Clin Oncol. 1993. PMID: 8093367

10

Expression of topoisomerase IIalpha is associated with rapid cell proliferation, aneuploidy, and c-erbB2 overexpression in breast cancer.

Järvinen TA, Kononen J, Pelto-Huikko M, Isola J. Järvinen TA, et al. Among authors: isola j. Am J Pathol. 1996 Jun;148(6):2073-82. Am J Pathol. 1996. PMID: 8669491 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

358 results

Search Page

Filters